BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 15486993)

  • 21. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
    Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
    Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
    Flowers LO; Subramaniam PS; Johnson HM
    Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
    Steiner H; Godoy-Tundidor S; Rogatsch H; Berger AP; Fuchs D; Comuzzi B; Bartsch G; Hobisch A; Culig Z
    Am J Pathol; 2003 Feb; 162(2):655-63. PubMed ID: 12547723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression of CCAAT/enhancer-binding protein delta mediated by autoregulation is repressed by related gene family proteins.
    Tanabe A; Kumahara C; Osada S; Nishihara T; Imagawa M
    Biol Pharm Bull; 2000 Dec; 23(12):1424-9. PubMed ID: 11145170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1.
    Cantwell CA; Sterneck E; Johnson PF
    Mol Cell Biol; 1998 Apr; 18(4):2108-17. PubMed ID: 9528783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factors NF-kappaB and C/EBPdelta and IL-1-induced expression of surfactant protein A in lung explants during the perinatal period.
    Seppänen O; Glumoff V; Paananen R; Rounioja S; Hallman M
    Biol Neonate; 2005; 87(3):152-9. PubMed ID: 15564781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signal transducer and activator of transcription 3 activates CCAAT enhancer-binding protein delta gene transcription in G0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland.
    Hutt JA; O'Rourke JP; DeWille J
    J Biol Chem; 2000 Sep; 275(37):29123-31. PubMed ID: 10867011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.
    Gao B; Shen X; Kunos G; Meng Q; Goldberg ID; Rosen EM; Fan S
    FEBS Lett; 2001 Jan; 488(3):179-84. PubMed ID: 11163768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncostatin M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein delta-dependent pathway.
    Hutt JA; DeWille JW
    Mol Cancer Ther; 2002 Jun; 1(8):601-10. PubMed ID: 12479220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
    Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
    Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN.
    Heo JY; Kim HJ; Kim SM; Park KR; Park SY; Kim SW; Nam D; Jang HJ; Lee SG; Ahn KS; Kim SH; Shim BS; Choi SH; Ahn KS
    Cancer Lett; 2011 Sep; 308(1):71-80. PubMed ID: 21565443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal regulation of H19 gene expression in prostate epithelial cells.
    Berteaux N; Lottin S; Adriaenssens E; Van Coppenolle F; Leroy X; Coll J; Dugimont T; Curgy JJ
    J Endocrinol; 2004 Oct; 183(1):69-78. PubMed ID: 15525575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway.
    Lo HW; Hsu SC; Ali-Seyed M; Gunduz M; Xia W; Wei Y; Bartholomeusz G; Shih JY; Hung MC
    Cancer Cell; 2005 Jun; 7(6):575-89. PubMed ID: 15950906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP.
    Spiotto MT; Chung TD
    Prostate; 2000 Feb; 42(2):88-98. PubMed ID: 10617865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
    Barton BE; Karras JG; Murphy TF; Barton A; Huang HF
    Mol Cancer Ther; 2004 Jan; 3(1):11-20. PubMed ID: 14749471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of CCAAT/enhancer-binding protein-delta (c/EBPdelta) in rat androgen-dependent tissues and human prostate cancer.
    Yang G; Gregory CW; Shang Q; O'Brien DA; Zhang YL
    J Androl; 2001; 22(3):471-80. PubMed ID: 11330648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.
    Jee SH; Chu CY; Chiu HC; Huang YL; Tsai WL; Liao YH; Kuo ML
    J Invest Dermatol; 2004 Dec; 123(6):1169-75. PubMed ID: 15610530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
    Kim J; Adam RM; Solomon KR; Freeman MR
    Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.